Trial intelligence / Profile preview

Dextrose plus levobupivacaine trigger point injection for myofascial pain syndrome

ChiCTR1800014444Phase 3Not yet recruiting

Sponsor
Anaesthesia office, CS5, 5/F, Kwong Wah Hospital, 25 Waterloo Road, Kln., HK
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dextrose and levobupivacaine in chronic myofascial pain (CMP) (2 arms), sponsored by Anaesthesia office, CS5, 5/F, Kwong Wah Hospital, 25 Waterloo Road, Kln., HK. Primary endpoint: Visual analogue scale. Planned start Feb 2018; status: not yet recruiting.

02

Drugs

dextroselevobupivacaine
03

Conditions

chronic myofascial pain (CMP)

Beyond the preview

Go deeper on ChiCTR1800014444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800014444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call